openPR Logo
Press release

Nonalcoholic Steatohepatitis Market: Global Industry Analysis and Forecast, 2014 – 2020

Nonalcoholic Steatohepatitis Market: Global Industry

Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is also known as silent liver disease. It is a type of nonalcoholic fatty liver disease (NAFLD), which mainly affects people with diabetes and obesity. Nonalcoholic Steatohepatitis (NASH) is defined by histological hallmarks of inflammation, hepatic steatosis, cell death, and fibrosis. A number of drugs used to treat medical situation have been NASH, such as amiodarone (Corderone, Pacerone), tamoxifen (Nolvadex), perhexiline maleate (Pexhid) and steroids (eg, prednisone). Medical studies have identified a strong connection of NASH with certain risk factors such as insulin resistance, oxidative stress and release of toxic inflammatory proteins.

Request Sample Report: http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=52719

Nonalcoholic steatohepatitis is a gradually becoming common chronic liver disease around the world and is closely related with diabetes and obesity. Rising incidence of NAFLD cases, changing lifestyle patterns, increasing rate of obesity and diabetes, and initiatives for research and development are the major driving factors of this market. However, insufficient information about the pathophysiology of NASH tissue and ineffective diagnostic technology for NASH is considered to restraint in this market.

The report includes detailed competitive landscape of the global nonalcoholic steatohepatitis market and an analysis of Porter’s five forces model for the nonalcoholic steatohepatitis market has also been included. It includes company market share analysis, product portfolio of the major industry participants. The report provides detailed segmentation of the nonalcoholic steatohepatitis market based on drugs type and region segment. GFT505, Obeticholic Acid (INT-747), Simtuzumab and Liraglutide (Victoza), Vitamin E, Poglitazone, Placebo is the drug type segment of nonalcoholic steatohepatitis market.

Do Inquiry before buying: http://goo.gl/67wZ4b

Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa with its further bifurcation into major countries including U.S., Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for nonalcoholic steatohepatitis based on individual products and applications in all the regions and countries. The nonalcoholic steatohepatitis market is dominated by North America followed by Asia Pacific. Asia pacific is expected to the fastest growing segment in the forecast period.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Intercepts Pharmaceuticals, Exalenz Bioscience Inc., Galectin Therapeutics Inc., Genfit, Gilead Science, AstraZeneca plc, Echosense SA, Raptor Pharmaceutical Corp, Matinas Biopharma Holdings Inc., Enzo Biochem, Inc., Galmed Pharmaceuticals Ltd., Perspectum Diagnostics and Novo Nordisk.

Browse detail report at: http://www.syndicatemarketresearch.com/market-analysis/nonalcoholic-steatohepatitis-market.html

This report segments the global nonalcoholic steatohepatitis market as follows:

Global Nonalcoholic Steatohepatitis Market: Drug Type Segment Analysis
GFT505
Obeticholic Acid (INT-747)
Simtuzumab and Liraglutide (Victoza)
Vitamin E
Poglitazone
Placebo

Global Nonalcoholic Steatohepatitis Market: Regional Segment Analysis
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East And Africa

Read Report TOC: http://goo.gl/Limjj2

About Us
Syndicate Market Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Syndicate Market Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.

Contact Us:
Syndicate Market Research
3422 SW 15 Street, Suit #8138,
Deerfield Beach,Florida 33442,
USATel: +1-386-310-3803GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@syndicatemarketresearch.com
Website: http://www.syndicatemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nonalcoholic Steatohepatitis Market: Global Industry Analysis and Forecast, 2014 – 2020 here

News-ID: 360591 • Views:

More Releases from Syndicate Market Research

Global Light Rail Vehicle Market Analysis by Size, Share, Key Drivers, Growth Opportunities and Global Trends 2028
Global Light Rail Vehicle Market Analysis by Size, Share, Key Drivers, Growth Op …
"A SWOT Analysis of Light Rail Vehicle, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down." Click here to access the report : https://www.syndicatemarketresearch.com/sample/light-rail-vehicle-market The global "Light Rail Vehicle market" research report portrays a deep analysis of the global Light Rail Vehicle market. The market value is calculated by analyzing the revenue (USD Million) and size (k.MT) of the global Light Rail Vehicle market.
Global High-mounted Stop Lamps Market Analysis, Revenue, Size, Price, Market Share, Growth Rate, Forecast to 2028
Global High-mounted Stop Lamps Market Analysis, Revenue, Size, Price, Market Sha …
"A SWOT Analysis of High-mounted Stop Lamps, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down." Click here to access the report : https://www.syndicatemarketresearch.com/sample/high-mounted-stop-lamps-market The global "High-mounted Stop Lamps market" research report portrays a deep analysis of the global High-mounted Stop Lamps market. The market value is calculated by analyzing the revenue (USD Million) and size (k.MT) of the global High-mounted Stop Lamps market.
Global Wiper Blade Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2030
Global Wiper Blade Market size,Share, Leading Players, Growth, Development and D …
"A SWOT Analysis of Wiper Blade, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down." Apply here for the FREE sample copy of the report @: https://www.syndicatemarketresearch.com/sample/wiper-blade-market The "Wiper Blade Market" research report presents an all-inclusive study of the global Wiper Blade market. The report includes all the major trends and technologies performing a major role in the Wiper Blade market development during forecast
Global Windshield Wiper Blades Market Analysis by Size, Share, Key Drivers, Growth Opportunities and Global Trends 2028
Global Windshield Wiper Blades Market Analysis by Size, Share, Key Drivers, Grow …
"A SWOT Analysis of Windshield Wiper Blades, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down." Click here to access the report : https://www.syndicatemarketresearch.com/sample/windshield-wiper-blades-market The global "Windshield Wiper Blades market" research report portrays a deep analysis of the global Windshield Wiper Blades market. The market value is calculated by analyzing the revenue (USD Million) and size (k.MT) of the global Windshield Wiper Blades market.

All 5 Releases


More Releases for Nonalcoholic

Nonalcoholic Steatohepatitis Treatment Market Analysis
As per the research conducted by GME, the Global Nonalcoholic Steatohepatitis Treatment Market will grow with a CAGR value of 39.1% by 2026. Over the forecast era, the production of NASH biomarkers is expected to be aided by increasing demand for non-invasive diagnostic tools and increased patient awareness. The low use of invasive procedures for disease diagnosis is due to the high cost of liver biopsy, its invasiveness, and patients'
Nonalcoholic Steatohepatitis Therapeutics Market: Trends, and Forecast 2025
According to a new market report published by Transparency Market Research “Nonalcoholic Steatohepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2025”, the nonalcoholic steatohepatitis (NASH) therapeutics market is anticipated to expand at a CAGR of 10.7% from 2015 to 2025 to reach US$20.27 bn by 2025. Nonalcoholic Steatohepatitis (NASH) is a syndrome that advances in patients who are not alcoholic; it causes liver damage
Nonalcoholic Drinks Market, Grow Substantially By 2022
Nonalcoholic drinks, also known as ‘virgin drinks’, ‘mocktails’ and ‘near beer’, refer to the beverages which comprise less than 0.5% of alcohol content by volume. Nonalcoholic drinks market encompasses a wide range of refreshment beverages, including energy drinks, juices, soft drinks, coffee & tea, bottled water, and probiotics. For More Info, Get Sample: http://bit.ly/2AFeSf6 The beverage industry has faced spectacular transformation in consumer preferences during a past decade. Consumers’
Growing Trends in Nonalcoholic Steatohepatitis Therapeutics Market till 2025
The global nonalcoholic steatohepatitis therapeutics market is dominated by companies such as Intercept Pharmaceuticals Inc., GENFIT SA, Galmed Pharmaceuticals Ltd., Zydus Cadila, AstraZeneca plc., Gilead Sciences, Inc., and Immuron Ltd. Key companies are focusing on the introduction of new drugs and therapeutics to treat nonalcoholic steatohepatitis (NASH). As per the Natural Medical Journal, the occurrence of nonalcoholic fatty liver diseases is expected to increase in the U.S., which is likely
Emerging Opportunities in Nonalcoholic Steatohepatitis Therapeutics Market
Global Nonalcoholic Steatohepatitis (NASH) Market: Snapshot Nonalcoholic Steatohepatitis (NASH), a syndrome found in non-alcoholic patients, causes damage to liver that is histologically akin to alcoholic hepatitis. NASH results from fat in the liver, along with inflammation. Symptoms in NASH usually do not show, but it can be severe and lead to cirrhosis, which is permanent damage to the liver. Those suffering from obesity, dyslipidemia, and glucose intolerance are most likely
03-23-2017 | Health & Medicine
TMR
Global Nonalcoholic Steatohepatitis Therapeutics Market
Nonalcoholic Steatohepatitis (NASH), also called the ‘silent disease,’ is a kind of fatty liver disease which typically affects people that are obese or diabetic. This disease is more prevalent in the younger generation and causes liver inflammation and/or damage owing to the accumulation of fat within the liver. The exact cause of this disease is still not clear; however, research activities are underway for finding effective treatments to cure this